News
The oesophageal microbiome and cancer: hope or hype?
The human oesophagus is home to a complex microbial community, the oesophageal microbiome.
Altering the microbiome for immunotherapy-resistant urological tumors-An intriguing but still early concept
The intestinal microbiome may play an important role in immunomodulation and affect treatment responses to immune checkpoint inhibitor therapy in genitourinary malignancies.
Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature
It is time for fecal microbiota transplantation to be suggested and tested in urological tumors resistant to immune checkpoint inhibitors. Clinical trials and investigations are ongoing in this field.
Press Releases
A trial of one of Igen Biolab Group’s products to investigate Age-Related Macular Degeneration (AMD) is approved
Javier Asarta, CEO of the Igen Biolab Group: “AMD affects some 700,000 people in Spain and currently has no treatment”.Dr Jordi Monés, study author: “As well as the medical benefits for patients, it reduces the socio-economic burden by preventing or improving the...
Biotech company Igen Biolab Group to raise up to EUR 15m for its clinical trials on lung cancer
Madrid, April 25, 2019.- Igen Biolab Group, a Spanish-based biotech company focused on the study of the microbiota impact on the prevention and treatment of cancer, and of neurodegenerative and metabolic diseases, has opened a financing round of up to 15 million euros...
New sponsorship for culture by IGEN Biotech
Among his Corporate Social Responsibility strategy, IGEN Biotech has expanded his programs of sponsorship on culture with a new agreement with the Culture Department of the regional Government of Catalonia (Spain), the Council of Barcelona, La Vanguardia,...
Events
7th International Congress on Probiotics, Prebiotics in Pediatrics
Scheduled to take place in Valencia, Spain on the 7th – 9th October, 2021, especially to those of you who have already registered in the congress.
34th Workshop of the European Helicobacter and Microbiota Study Group
34th Workshop of the European Helicobacter and Microbiota Study Group will be held online on September 18, 2021.
Asian Pacific Digestive Week 2021
The Local Organising Committee has made the decision to transform the APDW 2021, with the theme of ‘Vision of Excellence in Digestive Disorders & Sciences’ to a virtual conference, scheduled on 19 -22 August 2021.
Publications
The oesophageal microbiome and cancer: hope or hype?
The human oesophagus is home to a complex microbial community, the oesophageal microbiome.
Altering the microbiome for immunotherapy-resistant urological tumors-An intriguing but still early concept
The intestinal microbiome may play an important role in immunomodulation and affect treatment responses to immune checkpoint inhibitor therapy in genitourinary malignancies.
Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature
It is time for fecal microbiota transplantation to be suggested and tested in urological tumors resistant to immune checkpoint inhibitors. Clinical trials and investigations are ongoing in this field.